Altering the immune system to reverse paralysis

April 3, 2017, American Chemical Society
Researchers have developed an immunotherapy that, when given to paralyzed mice exhibiting a mouse model of multiple sclerosis (left), the mice regained the ability to walk (right) . Credit: American Chemical Society

In the ultimate betrayal, one's own immune system can turn against the protective sheath that envelops neurons in the brain, leaving the body paralyzed. Researchers have developed an experimental treatment that tames the wayward immune system in rodents, returning the power of movement to paralyzed mice. The approach may someday combat autoimmune diseases, such as multiple sclerosis and type 1 diabetes, in humans.

The researchers will present their work today at the 253rd National Meeting & Exposition of the American Chemical Society (ACS).

"The problem with current immunotherapies is that they aren't specific," says Christopher Jewell, Ph.D. "They act broadly, compromising the entire immune system and putting the patient's health at risk, rather than focusing on only those doing the damage."

By considering how the immune system works, Jewell's team at the University of Maryland set their sights on the as a possible target for creating a . In autoimmune disease, a body-roaming immune cell recognizes an antigen—a molecule that the cell in this case falsely identifies as a piece of a foreign invader—and brings it to the lymph nodes, where another type of immune cell, the T cell, is then programmed to attack the antigen. For example, in , T cells are taught to recognize and attack the myelin sheath. Jewell thought it might be possible to prevent the T cells from learning bad habits by delivering an immune-system modifying agent directly to the lymph nodes.

To build the immunotherapeutic agent, the researchers first constructed a particle from poly(lactide-co-glycolide), an FDA-approved polymer, to serve as a carrier. They infused it with an immune-suppressing agent and the myelin antigen, to teach the T cells that myelin is no enemy.

The researchers injected these particles into the lymph nodes of paralyzed mice exhibiting a mouse model of multiple sclerosis. The particles slowly reprogrammed the environment of the lymph node tissues to generate that migrated to the brain to stop the attack against myelin. These mice regained the ability to walk, and the effects lasted for the duration of the study, which was about 80 days. The mice were also able to readily respond when foreign molecules were introduced, suggesting that the treatment didn't compromise normal immune function.

As a next step, the researchers have been testing the idea in other mouse models of autoimmune disease, including transplant models and models of type 1 diabetes—a disease in which the immune system attacks the pancreas. Later this year, the group will team up with clinicians at the University of Maryland Medical School to begin tests in non-human primates, another step closer to investigating this idea as a future human therapy.

Explore further: Biomedical researchers break new ground in fight against multiple sclerosis

More information: Harnessing biomaterials to study and engineer lymph node function, the 253rd National Meeting & Exposition of the American Chemical Society (ACS), 2017.

Related Stories

Biomedical researchers break new ground in fight against multiple sclerosis

September 19, 2016
Researchers from the University of Maryland Fischell Department of Bioengineering and the University of Maryland School of Medicine report a new way to "turn off" the harmful immune attack that occurs during autoimmune diseases ...

Study reveals that adrenergic nerves control immune cells' daily schedule

October 31, 2016
Researchers in Japan have discovered that the adrenergic nervous system controls when white blood cells circulate through the body, boosting the immune response by retaining T and B cells in lymph nodes at the time of day ...

Multiple sclerosis: Newly discovered signal mechanism causes T cells to turn pathogenic

December 1, 2016
Multiple sclerosis is an autoimmune disease in which the body's immune system attacks the patient's own cells. In this case, modified T cells destroy the myelin sheath surrounding nerve cells. Myelin protects the neural pathways ...

Cargo-carrying red blood cells alleviate autoimmune diseases in mice

March 6, 2017
Using red blood cells modified to carry disease-specific antigens, scientists in the laboratories of Hidde Ploegh (former Whitehead Member, currently Boston Children's Hospital) and Harvey Lodish (Whitehead Founding Member) ...

Research reveals how lymph nodes expand during disease

October 22, 2014
Cancer Research UK and UCL scientists have discovered that the same specialised immune cells that patrol the body and spot infections also trigger the expansion of immune organs called lymph nodes, according to a study published ...

Solving a genetic mystery in type 1 diabetes

April 11, 2016
In type 1 diabetes, the immune system attacks the body's own insulin-producing cells. Scientists understand reasonably well how this autoimmune attack progresses, but they don't understand what triggers the attack or how ...

Recommended for you

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.